U.S. Markets open in 38 mins

Indivior PLC (INDV.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
70.00-54.40 (-43.73%)
As of 12:07PM GMT. Market open.

Indivior PLC

10710 Midlothian Turnpike
North Chesterfield, VA 23235
United States
804 379 1090
http://www.indivior.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees796

Key Executives

NameTitlePayExercisedYear Born
Mr. Mark CrossleyCEO & Exec. Director1.01MN/AN/A
Mr. Ryan PreblickCFO & Exec. DirectorN/AN/AN/A
Dr. Christian HeidbrederChief Scientific OfficerN/AN/AN/A
Mr. Jason ThompsonVP of Investor RelationsN/AN/AN/A
Mr. Javier RodriguezChief Legal OfficerN/AN/AN/A
Ms. Cynthia CetaniChief Integrity & Compliance OfficerN/AN/AN/A
Mr. Jon FogleChief HR OfficerN/AN/AN/A
Mr. Richard SimkinChief Commercial & Strategy OfficerN/AN/AN/A
Ms. Sue LearnedSr. VP of Global Clinical Devel.N/AN/AN/A
Hillel WestChief Manufacturing & Supply OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's products focuses on treating substance use disorder, opioid use disorder, and schizophrenia. It offers SUBLOCADE injection for subcutaneous use; SUBOXONE sublingual film; and PERSERIS for extended-release injectable suspension, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company is also involved in finance activities. It operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Corporate Governance

Indivior PLC’s ISS Governance QualityScore as of November 1, 2019 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.